A reliable cure for Helicobacter pylori infection?
作者信息
Graham D Y
机构信息
Veterans Affairs Medical Center (111D), Houston, Texas 77030, USA.
出版信息
Gut. 1995 Jul;37(1):154-6. doi: 10.1136/gut.37.1.154.
Abstract
摘要
相似文献
1
A reliable cure for Helicobacter pylori infection?幽门螺杆菌感染的可靠治愈方法？
Gut. 1995 Jul;37(1):154-6. doi: 10.1136/gut.37.1.154.
2
3
Helicobacter pylori eradication: a critical appraisal and current concerns.幽门螺杆菌根除：批判性评估与当前关注点
Scand J Gastroenterol Suppl. 1995;210:73-6.
4
Consensus for the management of Helicobacter pylori infection in children: still searching for a paradigm.儿童幽门螺杆菌感染管理的共识：仍在寻找一种范式。
Acta Gastroenterol Belg. 1998 Jul-Sep;61(3):316-20.
5
6
[Helicobacter pylori eradication: triple therapy versus dual therapy].[幽门螺杆菌根除：三联疗法与双联疗法]
Fortschr Med. 1996 Feb 10;114(4):34-8.
7
[Helicobacter pylori: 6-day triple therapy in duodenal ulcer. Study Group of Helicobacter pylori (GEHPY)].
Aten Primaria. 1998 Dec;22(10):668-9.
8
H. pylori: scientific basis to patient cure.幽门螺杆菌：从科学依据到治愈患者
Rev Gastroenterol Mex. 2006 Aug;71 Suppl 1:31-3.
9
Helicobacter pylori: why are eradication results so variable?
J Gastroenterol Hepatol. 2004 Jun;19(6):606-9. doi: 10.1111/j.1440-1746.2004.03453.x.
10
Antagonist: should we eradicate Helicobacter pylori in non-ulcer dyspepsia?
Gut. 2001 Jun;48(6):758-9. doi: 10.1136/gut.48.6.758.
引用本文的文献
1
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.幽门螺杆菌感染的治疗方法可得到改进：序贯疗法及其他。
Drugs. 2008;68(6):725-36. doi: 10.2165/00003495-200868060-00001.
2
One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm.幽门螺杆菌的一至两周三联疗法：疗效问题及纳入双重疗法治疗组
Gut. 2007 Jul;56(7):1021-3; author reply 1022-3. doi: 10.1136/gut.2006.118109.
3
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.韩国采用兰索拉唑、克拉霉素和甲硝唑进行为期一周的三联疗法治疗消化性溃疡疾病中的幽门螺杆菌感染。
Dig Dis Sci. 1998 Mar;43(3):464-7. doi: 10.1023/a:1018886318740.
4
Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains.在感染ICR小鼠模型中出现甲硝唑耐药幽门螺杆菌菌株以及甲硝唑耐药和敏感菌株根除情况的差异。
Antimicrob Agents Chemother. 1997 Dec;41(12):2602-5. doi: 10.1128/AAC.41.12.2602.
5
Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.幽门螺杆菌成功根除后的复发：本质及可能原因
Dig Dis Sci. 1997 Sep;42(9):1821-34. doi: 10.1023/a:1018827322470.
6
Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.兰索拉唑。其治疗酸相关性疾病的药理特性及临床疗效的最新进展。
Drugs. 1997 Sep;54(3):473-500. doi: 10.2165/00003495-199754030-00010.
7
1976 and all that!--20 years of antisecretory therapy.1976年及相关情况！——20年的抗分泌治疗。
Gut. 1996 Dec;39(6):784-6. doi: 10.1136/gut.39.6.784.
8
Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.荷兰原发性幽门螺杆菌对甲硝唑和克拉霉素的耐药率
Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):861-4. doi: 10.1007/BF01691216.
9
How should we decide on the best regimen for eradicating Helicobacter pylori?
BMJ. 1995 Sep 2;311(7005):581-2. doi: 10.1136/bmj.311.7005.581.
本文引用的文献
1
Evolution of concepts regarding Helicobacter pylori: from a cause of gastritis to a public health problem.幽门螺杆菌相关概念的演变：从胃炎病因到公共卫生问题。
Am J Gastroenterol. 1994 Apr;89(4):469-72.
2
The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.在规划实验时使用预测置信区间以及在解释结果时对功效的误用。
Ann Intern Med. 1994 Aug 1;121(3):200-6. doi: 10.7326/0003-4819-121-3-199408010-00008.
3
Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.
Am J Gastroenterol. 1994 Nov;89(11):1993-7.
4
In vivo susceptibility of Campylobacter pylori.幽门螺杆菌的体内易感性。
Am J Gastroenterol. 1989 Mar;84(3):233-8.
5
Sample sizes for constructing confidence intervals and testing hypotheses.
Stat Med. 1989 Jul;8(7):803-11. doi: 10.1002/sim.4780080705.
6
Factors influencing the eradication of Helicobacter pylori with triple therapy.影响三联疗法根除幽门螺杆菌的因素。
Gastroenterology. 1992 Feb;102(2):493-6. doi: 10.1016/0016-5085(92)90095-g.
Zotero 插件